Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New drug evaluations. Triazolam.

P D Kroboth, R P Juhl

    Drug Intelligence & Clinical Pharmacy
    |July 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Triazolam, a triazolobenzodiazepine, effectively treats insomnia by reducing sleep latency and nighttime awakenings. It improves daytime alertness without negatively impacting performance, with common side effects like drowsiness.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Options for people who have heartburn.

    Postgraduate medicine·2009
    Same author

    Dysregulation of neurosteroids in obsessive compulsive disorder.

    Journal of psychiatric research·2008
    Same author

    Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults.

    Biological psychiatry·2001
    Same author

    Dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol concentrations in intensive care unit patients.

    Critical care medicine·2001
    Same author

    Sex differences in the pharmacokinetics of dehydroepiandrosterone (DHEA) after single- and multiple-dose administration in healthy older adults.

    Journal of clinical pharmacology·2000
    Same author

    Clonazepam and sertraline: absence of drug interaction in a multiple-dose study.

    Journal of clinical psychopharmacology·2000
    Same journal

    Profile of prescription medication in a pediatric population.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    SI units in drug therapeutics.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Physicians' review of significant interventions by clinical pharmacists in inpatient care.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Possible interaction of ranitidine with phenytoin.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Famotidine-associated mental confusion in elderly patients.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Intravenous self-administration of elemental mercury: efficacy of dimercaprol therapy.

    Drug intelligence & clinical pharmacy·1988
    See all related articles

    Area of Science:

    • Pharmacology
    • Sleep Medicine
    • Neuroscience

    Background:

    • Triazolam is a triazolobenzodiazepine sedative/hypnotic.
    • It is structurally related to alprazolam.
    • Recently approved for short-term insomnia management.

    Purpose of the Study:

    • Evaluate triazolam's efficacy and safety in treating insomnia.
    • Assess its effects on sleep architecture and daytime function.

    Main Methods:

    • Clinical trials assessing sleep latency, nocturnal awakenings, and total sleep time.
    • Sleep electroencephalogram (EEG) studies.
    • Performance and alertness assessments.

    Main Results:

    • Triazolam decreased sleep latency and nocturnal awakenings, increasing total sleep time.

    Related Experiment Videos

  • No significant effect on delta-sleep; variable effects on REM sleep.
  • Improved or no change in daytime alertness and performance; common side effects include drowsiness, dizziness, and dry mouth.

    • Conclusions:

    • Triazolam is effective for short-term insomnia management.
    • It positively impacts sleep quality and daytime function.
    • Standard dosage is 0.25-0.5 mg hs, with a lower dose for geriatric patients.